NCT03855176View on ClinicalTrials.gov

Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

September 12, 2017

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
Hepatitis AHuman Immunodeficiency VirusVaccine Response Impaired
Interventions
DRUG

Vaqta Injectable Product

Inactive vaccine against hepatitis A virus

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT03855176 - Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients | Biotech Hunter | Biotech Hunter